This report, curated by our Beacon Checkpoint experts, delves into both the drug and trial landscapes and spotlights the top five oncology indications. Inside these domains, you’ll uncover:
- A round-up of the top ten targets being studied
- An overview of the leading developers in both the clinical and preclinical settings and their assets
- An analysis of the progression of checkpoint trials over time and their phase distribution
- Insights into routes of administration, mechanisms of action, combination trials, and more!
To learn more about this report, or how Beacon Checkpoint can enhance your data needs and provide fast insights, please book a research session below or contact us directly on email@example.com.